The DC-recorded dog electroretinogram in ketamine-medetomidine anaesthesia

氯胺酮-美托咪定麻醉下犬的直流记录视网膜电图

阅读:1

Abstract

A new selective alpha 2-adre-noreceptor agonist, medetomidine hydrochloride was combined with low dosage ketamine hydrochloride and vecuronium bromide for d.c. (direct current) recordings of fast electroretinographic (ERG) components in nine ophthalmoscopically healthy dark adapted dogs. The dogs were tracheally intubated and manually ventilated. They were given full field single flash stimuli of different intensities starting with near b-wave threshold blue light (tests 1-3), followed by white light (tests 4-6) and 30 Hz photopic flicker (test 7). The a- and b-wave amplitudes and flicker responses were measured from the base line. The latencies were measured from the stimulus moment to the highest point of the different waves. Statistical analysis of results gave individual differencies which had a good constancy. This showed that the dogs had an individual ERG profile according to the standardized method. The latencies varied very little as expected, but the amplitudes differed individually and showed a good constancy as seen by reproducibility tests made nine to ten days later on three of the dogs’ ipsilateral eyes. The combination of drugs used in this study was considered suitable for short term (10-12 minutes) stable d.c.–ERG recordings in dogs as the rod and cone responses had higher amplitudes when compared to an identical examination made with other anaesthetic combinations on the same dogs. Involuntary eye movements and other involuntary muscular activity caused by ketamine in dogs were negligible when using medetomidine premedication and was completely absent when using vecuronium. The anaesthetic method described can be recommended for ambulatory ERG recordings in dogs because of the above mentioned advantages.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。